Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2007
12/13/2007WO2007087548A3 Chemical compounds
12/13/2007WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
12/13/2007US20070287701 6-({[(1-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
12/13/2007DE19756888B4 Reversibles wärmeempfindliches Aufzeichnungsmaterial, Verfahren zur Herstellung, Aufzeichnungsverfahren und Beschichtungsflüssigkeit A reversible thermosensitive recording material, methods of making, recording method, and the coating liquid
12/13/2007CA2654445A1 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
12/12/2007EP1863820A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases
12/12/2007EP1863774A2 Heterocyclical chromophore architectures with novel electronic acceptor systems
12/12/2007EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007EP1564212B1 Process and intermediates for obtaining 1-(1h-benzimidazol-2-yl)-4-(pyrimidin-2-ylamino)piperidine derivatives
12/12/2007EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007CN101087783A Trisubstituted thiophenes as progesterone receptor modulators
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN101087611A Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
12/12/2007CN101085778A Preparation method for etodolac
12/12/2007CN101085041A Total alkaloid of lotus leaves extraction and its preparation method
12/12/2007CN100354279C Novel camptothecin derivatives and their preparation process and use
12/12/2007CN100354278C Quinazoline derivatives as SRC tyrosine kinase inhibitors
12/12/2007CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/11/2007US7307162 Resolution of a narwedine amide derivative
12/11/2007US7307084 Gastric secretion inhibiting and excellent gastric and intestinal protective action properties, gastrointestinal disorder
12/11/2007US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide
12/11/2007US7307044 Use as insecticides, fungicides and/or herbicides; e.g. 3-(2-methyl-5-(4-chloro-phenyl)phenyl)-3-chloro-5,5-dimethyl-pyrrolidin-2,4-dione
12/11/2007CA2413510C Condensed pyrazindione derivatives
12/06/2007WO2007140297A2 Aziridinyl-epothilone compounds
12/06/2007WO2007138408A1 11c/18 f-labeled inhibitors of glycogen synthase kinase-3
12/06/2007WO2007138017A1 1h-furo[3,2-c] pyrazole compounds useful as kinase inhibitors
12/06/2007WO2007137738A1 Spirocyclic nitriles as protease inhibitors
12/06/2007WO2007056550A3 Processes for preparation of maytansinol
12/06/2007WO2005069865A3 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
12/06/2007US20070281959 Glucocorticoid receptor modulator compounds and methods
12/06/2007US20070281946 Tri(cyclo) substituted amide compounds
12/06/2007US20070281930 bicyclic bisamides for controlling acarina
12/06/2007US20070281917 HIV Integrase Inhibitors
12/06/2007CA2655668A1 Aziridinyl-epothilone compounds
12/06/2007CA2653662A1 Spirocyclic nitriles as protease inhibitors
12/06/2007CA2653529A1 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/05/2007EP1861373A2 Processes for preparing morphinans and intermediates thereof
12/05/2007EP1861105A1 Process for the preparation of galanthamine hydrobromide
12/05/2007EP1861092A1 Potassium channel opener having benzofuroindole skeleton
12/05/2007CN101084223A Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors
12/05/2007CN101084221A Stereoselective process and crystalline forms of a camptothecin
12/05/2007CN100352820C Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
12/04/2007US7304157 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304072 Spiro compounds
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
12/04/2007CA2193097C Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides
11/2007
11/29/2007WO2007136106A1 Novel epoxy compound and method for producing the same
11/29/2007WO2007134625A1 New benzothiazinone derivatives and their use as antibacterial agents
11/29/2007WO2007134485A1 Aporphine and oxoaporphine compounds and pharmaceutical use thereof
11/29/2007WO2007134434A1 Phenanthrene derivatives as mpges-1 inhibitors
11/29/2007WO2007120599A3 Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
11/29/2007WO2007075895A3 Heterocyclic derivatives as modulators of ion channels
11/29/2007WO2006106326A8 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/29/2007US20070276018 Aziridinyl-epothilone compounds
11/29/2007US20070275994 Novel Antinfective Compounds
11/29/2007US20070275992 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers
11/29/2007US20070275984 Novel Thieno-Pyridine and Thieno-Pyrimidine Derivatives and Their Use as Positive Allosteric Modulators of Mglur2-Receptors
11/29/2007US20070275962 Heterobicyclic Compounds as Pharmaceutically Active Agents
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007CA2652841A1 New benzothiazinone derivatives and their use as antibacterial agents
11/29/2007CA2652238A1 Phenanthrene derivatives as mpges-1 inhibitors
11/28/2007EP1860110A1 Cyclodextrins functionalised with etodolac as specific site release agents
11/28/2007EP1860109A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
11/28/2007EP1860108A1 Enantiomers of Amino Pyrimidine compounds for the treatment of inflammatory disorders
11/28/2007EP1858897A1 Isolation of galanthamine from biological material
11/28/2007EP1858853A2 Novel pyridine derivatives as potassium ion channel openers
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007CN101080395A Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
11/28/2007CN101080394A Heterocyclical chromophore architectures
11/28/2007CN101080231A Method for preparing galantamine hydrobromide
11/28/2007CN101077872A Method for preparing etodolac methyl ester
11/28/2007CN100351256C Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/27/2007US7301019 Method for the preparation of maytansinoid esters
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007WO2007133155A1 Nicotinic acetylcholine receptor ligands 101
11/22/2007WO2007133112A1 Noscapine derivatives (variants), combinatory and focused library, pharmaceutical composition, methods for the production (variants) and the use thereof
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007US20070270585 Cytotoxic agents comprising new maytansinoids
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070270400 New compounds 303
11/22/2007US20070269855 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof
11/22/2007CA2652610A1 Nicotinic acetylcholine receptor ligands 101
11/21/2007EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same
11/21/2007EP1857107A1 Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion
11/21/2007EP1856124A1 New synthesis of a camptothecin subunit
11/21/2007EP1856123A2 Small molecule inhibitors of mdm2 and uses thereof
11/21/2007EP1856117A1 Indolopyridines, benzofuranopyridines and benzothienopyridines
11/21/2007EP1856079A1 Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 298